Mixed hematopoietic chimerism after marrow allografts. Transplantation in the ambulatory care setting.
This paper describes the development of nonmyeloablative marrow transplant programs that have little toxicity in a canine model and their translation to patients with malignant and nonmalignant hematological diseases.